GW PHARMACEUTICALS PLC Operating Lease Cost
GW PHARMACEUTICALS PLC reported Operating Lease Cost of $8.89 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2021-02-26
- GW PHARMACEUTICALS PLC operating lease, cost for the quarter ending 2019-12-31 was $2.37M.
- GW PHARMACEUTICALS PLC operating lease, cost for the quarter ending 2019-09-30 was $1.83M.
- GW PHARMACEUTICALS PLC operating lease, cost for the quarter ending 2019-06-30 was $1.83M.
- GW PHARMACEUTICALS PLC operating lease, cost for the quarter ending 2019-03-31 was $1.42M.
- GW PHARMACEUTICALS PLC operating lease, cost for fiscal 2020 was $8.89M, a 19.41% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC operating lease, cost for fiscal 2019 was $7.45M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2020-12-31 | $8.89M 10-K · filed 2021-02-26 | |||
| 2019-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $4.20M derived: sum of 2 quarters · filed 2021-02-26 | $6.02M derived: sum of 3 quarters · filed 2021-02-26 | $7.45M 10-K · filed 2021-02-26 |
| 2019-09-30 | $1.83M 10-Q · filed 2019-11-06 | $3.66M derived: sum of 2 quarters · filed 2019-11-06 | $5.08M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.83M 10-Q · filed 2019-08-07 | $3.25M 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $1.42M 10-Q · filed 2019-05-08 |